Our Strategy

AT’s goal is to bring new medicines to market that address the clear unmet medical need of patients suffering with autism and related disorders and to become the world’s leading platform in autism and related disorders drug research, development, and commercialization. Building upon a first in class network of prominent researchers and Autism Therapeutics’  clinical development expertise, we aim to design smart, cost effective development plans that lead to regulatory approvals in a timely manner. AT also considers establishing key commercialization partnerships with leading pharmaceutical companies in select territories as key to the Company’s global success.